fbpx Skip to main content

WEDNESDAY, Jan. 27, 2021 (HealthDay News) — Diabetes is associated with increased odds of contracting COVID-19 and with increased COVID-19 mortality, while metformin treatment before diagnosis of COVID-19 is associated with reduced odds of related mortality, according to a study published online Jan. 13 in Frontiers in Endocrinology.

Andrew B. Crouse, Ph.D., from the Hugh Kaul Precision Medicine Institute at the University of Alabama at Birmingham, and colleagues conducted a retrospective health record data analysis of 25,326 individuals tested for COVID-19 between Feb. 25 and June 22, 2020. The association between mortality in COVID-19-positive individuals and patient characteristics and comorbidities was examined.

The researchers found that Blacks/African Americans and those with obesity, hypertension, and diabetes had disproportionately higher odds of contracting COVID-19 (odds ratios, 2.6, 1.93, 2.46, and 2.11, respectively). There was also an association for diabetes with increased mortality (odds ratio, 3.62), which emerged as an independent risk factor even after adjustment for age, race, sex, obesity, and hypertension. For individuals with diabetes and COVID-19, metformin treatment prior to COVID-19 diagnosis was independently associated with reduced mortality (odds ratio, 0.33).

“These results suggest that, while diabetes is an independent risk factor for COVID-19-related mortality, this risk is dramatically reduced in subjects taking metformin — raising the possibility that metformin may provide a protective approach in this high-risk population,” a coauthor said in a statement.

Abstract/Full Text

You May Also Like::  CDC Broadens Definition of 'Close Contact' in Tracing COVID-19 Infections

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More